Endothelin-1 (ET-1) could play a role in the regulation of aldosterone secr
etion of the human adrenal gland. The presence of the endothelin-converting
enzyme 1 (ECE-1) and ET-1 suggests that there is a local ET system in the
adrenal cortex, but the in situ synthesis of ET-1 remains to be confirmed.
The cellular distribution of the whole ET system was evaluated in 20 cases
of aldosterone-producing adenomas. Polymerase chain reaction studies gave s
trong signals for ECE-1 mRNA and the mRNAs for endothelin type A (ETA) and
B (ETB) receptors and faint signals for prepro-ET-1 mRNA. In situ hybridiza
tion showed ETA receptors scattered throughout the adenoma, in both secreto
ry cells and vascular structures (score, +). There were more ETB receptors
(score, + +), but they were restricted mainly to the endothelium. ECE-1 mRN
A and protein were ubiquitous and abundant in secretory cells (score, + + ) and vascular structures (score, + +); the enzyme was active on big ET-1.
There was no prepro-ET-1 mRNA in the cortex, except in the thickened precap
illary arterioles present in only 30% of the aldosterone-producing adenomas
studied. ET-1 immunoreactivity was detected in vascular structures (score,
+), probably bound to receptors, suggesting that ET-1 has an endocrine act
ion. The low concentrations of ET-1 could also indicate that it acts in a p
aracrine-autocrine fashion to control adrenal blood flow. The discrepancy b
etween the concentrations of ECE-1 and its substrate suggests that ECE-1 ha
s another role in the adrenal secretory cells. Our data indicate that ET pr
obably is not a primary cause of the development or maintenance of the aden
oma.